Listed

Nortech Systems Inc: Form 10-Q for the period ended Mar 31, 2018

Filed with the SEC on May 11, 2018 and accepted by EDGAR at May 11, 2018, 11:46 ET.

Share

Management's discussion and analysis

As filed, 15,608 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Overview

We are a Maple Grove, Minnesota based full-service electronics manufacturing services (“EMS”) contract manufacturer of wire and cable assemblies, printed circuit board assemblies, higher-level assemblies and box builds for a wide range of industries. We provide value added engineering services and technical support including design, testing, prototyping and supply chain management to customers mainly in the aerospace and defense, medical, and industrial equipment markets. We maintain facilities in Bemidji, Blue Earth, Eden Prairie, Mankato, Merrifield, and Milaca, Minnesota; Monterrey, Mexico; and Suzhou, China. All of our facilities are certified to one or more of the ISO/AS standards, including 9001, AS9100 and 13485, with most having additional certifications based on the needs of the customers they serve.

Results of Operations

The following table presents statements of operations data as percentages of total net sales for the periods indicated:

March 31, 2018 2017
Net Sales 100.0% 100.0%
Cost of Goods Sold 88.5 89.1
Gross Profit 11.5 10.9
Selling Expenses 3.9 4.3
General and Administrative Expenses 8.0 7.5
Gain on Sale of Property and Equipment 0.0 (1.3)
Income (Loss) from Operations (0.4) 0.4
Other Expenses (0.7) (0.5)
Loss Before Income Taxes (1.1) (0.1)
Income Tax Expense (Benefit) 0.4 0.0
Net Loss (1.5)% (0.1)%

Net Sales

Net sales were $26.4 million in the first quarter of 2018, as compared to $28.3 million in the first quarter of the prior year, a decrease of $1.9 million or 6.7%. Our 2018 amounts include $0.7 million of additional sales related to the change in the revenue recognition policy. Net sales results were varied by markets, the medical market decreased by $3.5 million or 25.5% with medical component products accounting for 50% of the decrease and medical devices the remaining 50%. The industrial market sector was up $0.2 million or 1.4% of sales in the first quarter of 2018 as compared to the same quarter of 2017. Net sales from the aerospace and defense markets increased by $1.5 million or 45.2% in the first quarter of 2018 as compared to the first quarter of 2017.

Net sales by our major EMS industry markets for the three months ended March 31, 2018 and 2017 were as follows (in thousands):

As Reported% 2018 2017 Change
Aerospace and Defense $4,866 $3,351 45.2
Medical 10,321 13,858 (25.5)
Industrial 11,260 11,109 1.4
Total Net Sales $26,447 $28,318 (6.6)

Net sales by our major EMS industry markets for the three months ended March 31, 2018, to the pro-forma amounts for the same period had the previous guidance been in effect (in thousands):

As Reported 2018 Pro forma as if the previous accounting guidance was in effect % Change
Aerospace and Defense $4,866 $4,679 4.0
Medical 10,321 10,108 2.1
Industrial 11,260 10,943 2.9
Total Net Sales $26,447 $25,730 2.8

Net sales by timing of transfer of goods and services for the three months ended March 31, 2018 is as follows (in thousands):

Product/ Service Transferred Over Time Product Transferred at Point in Time Noncash Consideration Total Net Sales by Market
Aerospace and Defense $4,623 $48 $195 $4,866
Medical 9,434 482 405 10,321
Industrial 9,992 843 425 11,260
Total Net sales $24,049 $1,373 $1,025 $26,447

Backlog

Our 90-day shipment backlog as of March 31, 2018 was $21.9 million, a 12.9% increase from the beginning of the quarter and a 6.5% decrease as compared to the prior year. Backlog for our medical customers has increased 51.7% from the beginning of the quarter and decreased 19.8% compared to the prior year. The aerospace and defense backlog increased 5.1% from the beginning of the quarter and increased 26.6% from the prior year. Our industrial customers’ backlog decreased 12.2% from the beginning of the quarter and decreased 3.4% from the prior year. Our backlog consists of firm purchase orders we expect to ship in the next 90 days, with any remaining amounts to be transferred within 180 days.

90-day shipment backlog by our major EMS industry markets are as follows (in thousands):

Shipment Backlog as of the Quarter Ended March 31, 2018 December 31, 2017 March 31, 2017
Aerospace and Defense $5,220 $4,968 $4,122
Medical 9,556 6,302 11,917
Industrial 7,166 8,165 7,418
Total Backlog $21,942 $19,435 $23,457

Our 90-day backlog varies due to order size, manufacturing delays, contract terms and conditions and timing from customer delivery schedules and releases. These variables cause inconsistencies in comparing the backlog from one period to the next.

Gross Profit

Gross profit as a percent of net sales for the three months ended March 31, 2018 and 2017, was 11.5% and 10.9%, respectively. The improvement in gross profit in the first quarter of 2018 was driven by product mix and cost improvements as we adjusted to current revenue levels. In addition, we recognized revenue of $1.0 million related to the noncash consideration recorded at zero margin as a result of implementing revenue recognition.

Selling Expense

Selling expenses for the three months ended March 31, 2018 and 2017 was $1.0 million or 3.9% of sales and $1.2 million or 4.3% of sales, respectively. The decrease in selling expenses for 2018 is due to budget reductions and lower sales incentives.

General and Administrative Expense

General and administrative expenses for the three months ended March 31, 2018 and 2017, were $2.1 million or 8.0% of sales and $2.1 million or 7.5% of sales, respectively.

Gain from Sale of Property and Equipment

There was no sales of property and equipment recorded for the three months ended March 31, 2018. Net gain from sale of property and equipment for the quarter ended March 31, 2017 was $0.4 million from the sale of the Augusta building and building improvements (see Note 7).

Loss from Operations

First quarter 2018 loss from operations was $0.1 million compared to income of $0.1 million for the first quarter in 2017 after the $0.4 million gain from the sale of the Augusta building.

Income Taxes

On a quarterly basis, we estimate what our effective tax rate will be for the full fiscal year and record a quarterly income tax provision based on the anticipated rate. As the year progresses, we refine our estimate based on the facts and circumstances, including discrete events, by each tax jurisdiction. Our effective tax rate for the three months ended March 31, 2018 and 2017 was (34%) and 23%, respectively. The effective tax rate for the year ended December 31, 2018 is expected to be 56% compared to (18%) for the year ended December 31, 2017. The increase is due mainly to the effects of the tax reform changes that were enacted on December 22, 2017, and the increase in the effective tax rate expected in China.

Net Loss

Net loss for the three months ended March 31, 2018 was $0.4 million or ($0.14) per basic and diluted common share, compared to a net loss for the three months ended March 31, 2017 of $15,000 or ($0.01) per basic and diluted common share.

Liquidity and Capital Resources

Net cash provided by operating activities for the three months ended March 31, 2018 was $0.5 million. The noncash addback of depreciation and amortization, along with an increase in accrued liabilities and a decrease in inventory and contract assets, has positively impacted cash flows, offset by an increase in accounts receivable.

Net cash used in investing activities of $0.3 million for the three months ended March 31, 2018, was the result of property and equipment purchases to support the business.

We have satisfied our liquidity needs over the past several years with cash flows generated from operations and a bank operating line of credit. We have a credit agreement with Bank of America (BofA) which was entered into on June 15, 2017 and amended on December 29, 2017 and provides for a line of credit arrangement of $16.0 million that expires on June 15, 2022. The credit arrangement also has a $5.0 million real estate term note outstanding with a maturity date of June 15, 2022.

Both the line of credit and real estate term notes are subject to fluctuations in the LIBOR rates. The line of credit and real estate term notes with BofA contain certain covenants which, among other things, require us to adhere to regular reporting requirements, abide by annual shareholder dividend limitations, maintain certain financial performance, and limit the amount of annual capital expenditures. The availability under our line is subject to borrowing base requirements, and advances are at the discretion of the lender. The line of credit is secured by substantially all of our assets.

On March 31, 2018, we had outstanding advances of $8.6 million under the line of credit and unused availability of $3.9 million supported by our borrowing base. We believe our financing arrangements and cash flows to be provided by operations will be sufficient to satisfy our future working capital needs. Our working capital was $20.7 million and $19.7 million as of March 31, 2018 and December 31, 2017, respectively.

The Bank of America credit agreement as amended provides for, among other things, a fixed charge coverage ratio of not less than (i) 1.0 to 1.0 for each period of four fiscal quarters, commencing with the period of four fiscal quarters ending December 31, 2018. In addition, the agreement requires that the Company comply with certain minimum levels of cumulative EBITDA for measurement periods during fiscal 2018, including cumulative EBITDA of $2.0 million for the twelve months ending December 31, 2018.

Cash conversion cycle:

Three Months Ended March 31, 2018 March 31, 2017
Days in trade accounts receivable 58 54
Days in inventory 53 78
Days in accounts payable (45) (54)
Cash conversion cycle 66 78
Cash conversion cycle without adoption of ASU 2014-09 88 78

20

We calculate days in accounts receivable as accounts receivable for the respective quarter divided by annualized sales for the respective quarter by day. We calculate days in inventory and accounts payable as each balance sheet line item for the respective quarter divided by annualized cost of sales for the respective quarter by day. We calculate cash conversion cycle as the sum of days in receivable and inventory less days in accounts payable. Items which may cause the cash conversion cycle in a particular period to differ include, but are not limited to, changes in business mix, changes in payment terms and the timing of revenue recognition and inventory purchases within the period. Days in inventory for the three months ended March 31, 2018 decreased as compared to the three months ended March 31, 2017 primarily related to the adoption of ASU 2014-09 and the recognition of revenue over time rather than upon shipment of inventory. The increase in days in accounts receivable related to increased payment terms requested by our customers and a decrease in days in accounts payable, as a result of the timing of payments.

Off-Balance Sheet Arrangements

We have not engaged in any off-balance sheet activities as defined in Item 303(a)(4) of Regulation S-K.

Critical Accounting Policies and Estimates

Our significant accounting policies and estimates are summarized in Management’s Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report on Form 10-K for the year ended December 31, 2017. There has been significant changes to our critical accounting policies since December 31, 2017, related to the implementation of the FASB issued Accounting Standards Update (“ASU”) 2014-09, “Revenue from Contracts with Customers (Topic 606)” (“ASU 2014-09”), refer to Note 1 and Note 3. The adoption of the new revenue standard had a significant impact on our results of operations, cash flows, and financial position. Some of our accounting policies require us to exercise significant judgment in selecting the appropriate assumptions for calculating financial estimates. Such judgments are subject to an inherent degree of uncertainty. These judgments are based on our historical experience, known trends in our industry, terms of existing contracts and other information from outside sources, as appropriate. Actual results could differ from these estimates.

Forward-Looking Statements

Those statements in the foregoing report that are not historical facts are forward-looking statements made pursuant to the safe-harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements generally will be accompanied by words such as “anticipate,” “believe,” “estimate,” “expect,” “forecast,” “intend,” “possible,” “potential,” “predict,” “project,” or other similar words that convey the uncertainty of future events or outcomes. Although we believe these forward-looking statements are reasonable, they are based upon a number of assumptions concerning future conditions, any or all of which may ultimately prove to be inaccurate. Forward-looking statements involve a number of risks and uncertainties. Important factors that could cause actual results to differ materially from the forward-looking statements include, without limitation:

  • Volatility in the marketplace which may affect market supply and demand for our products or currency exchange rates;
  • Increased competition from within the EMS industry or the decision of OEMs to cease or limit outsourcing;
  • Changes in the reliability and efficiency of operating facilities or those of third parties;
  • Risks related to availability of labor;
  • Increase in certain raw material costs such as copper and oil;
  • Commodity and energy cost instability;
  • Risks related to FDA noncompliance;
  • Loss of a major customer;
  • Increased or unanticipated costs related to compliance with securities and environmental regulation;
  • General economic, financial and business conditions that could affect our financial condition and results of operations; and
  • Disruption of global or local information management systems due to natural disaster or cyber-security incident.

The factors identified above are believed to be important factors (but not necessarily all of the important factors) that could cause actual results to differ materially from those expressed in any forward-looking statement made by us. Discussion of these factors is also incorporated in Part I, Item 1A, “Risk Factors,” and should be considered an integral part of Part II, Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” Unpredictable or unknown factors not discussed herein could also have material adverse effects on forward-looking statements. All forward-looking statements included in this Form 10-Q are expressly qualified in their entirety by the forgoing cautionary statements. We undertake no obligations to update publicly any forward-looking statement (or its associated cautionary language) whether as a result of new information or future events.

Please refer to forward-looking statements and risks as previously disclosed in our Annual Report on Form 10-K for the fiscal year ended December 31, 2017.

Controls and procedures

As filed, 2,190 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Evaluation of Disclosure Controls and Procedures

In accordance with Rule 13a-15(b) of the Securities Exchange Act of 1934 (the “Exchange Act”), as of the end of the period covered by this Quarterly Report on Form 10-Q, our management evaluated, with the participation of our Chief Executive Officer and Chief Financial Officer, the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) and Rule 15d-15(e) under the Exchange Act). These controls and procedures are designed to ensure that information required to be disclosed in the Company’s Exchange Act reports is (1) recorded, processed, summarized and reported in a timely manner, and (2) accumulated and communicated to management, including the Company’s Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. Based upon their evaluation of these disclosure controls and procedures as of the date of the evaluation, the Chief Executive Officer and Chief Financial Officer concluded that the disclosure controls and procedures were effective.

Changes in Internal Control Over Financial Reporting

Beginning January 1, 2018, we implemented the FASB issued Accounting Standards Update (“ASU”) 2014-09, “Revenue from Contracts with Customers (Topic 606)” (“ASU 2014-09”). The adoption of the new revenue standard had a significant impact on our results of operations, cash flows, and financial position, requiring us to implement changes to our controls related to revenue (see Note 1). These included the development of new policies based on the five-step model provided in the new revenue standard, enhanced contract review requirements, and other ongoing monitoring activities. These controls were designed to provide assurance at a reasonable level of the fair presentation of our condensed consolidated financial statements and related disclosures. There was no other change in our internal control over financial reporting during our most recently completed fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2018-03-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Cost of revenue3 months2018-01-01 to 2018-03-31$23.4mus-gaap:CostOfGoodsAndServicesSold
Gross profit3 months2018-01-01 to 2018-03-31$3.0mus-gaap:GrossProfit
Operating income3 months2018-01-01 to 2018-03-31−$120.0kus-gaap:OperatingIncomeLoss
Interest expense3 months2018-01-01 to 2018-03-31$172.0kus-gaap:InterestExpense
Income tax3 months2018-01-01 to 2018-03-31$99.0kus-gaap:IncomeTaxExpenseBenefit
Net income3 months2018-01-01 to 2018-03-31−$391.0kus-gaap:NetIncomeLoss
Diluted EPS3 months2018-01-01 to 2018-03-31−$0.14us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow3 months2018-01-01 to 2018-03-31$542.0kus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure3 months2018-01-01 to 2018-03-31$288.0kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Share repurchases3 months2018-01-01 to 2018-03-31$126.0kus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2018-03-31$466.0kus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2018-03-31$39.1mus-gaap:AssetsCurrent
Total assetsAt period end2018-03-31$53.3mus-gaap:Assets
Current liabilitiesAt period end2018-03-31$18.4mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2018-03-31$32.5mus-gaap:Liabilities
Long-term debtAt period end2018-03-31$4.2mus-gaap:LongTermDebtNoncurrent
Current portion of debtAt period end2018-03-31$1.0mus-gaap:LongTermDebtCurrent
Shareholders' equityAt period end2018-03-31$20.8mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001104659-18-032426. Last ingested by Listed: Nov 12, 2026, 19:20 ET. Listed shows no prices and gives no investment advice.